Sequencing Considerations in mCRPC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Sequencing Considerations in mCRPC

Genetics/Genomics in Prostate Cancer

By Stanford Medicine FEATURING Matthew Cooperberg

91 views

July 9, 2022

Comments 0

Lecture Summary - CARD Trial: Safety and Efficacy of Cabazitaxel in …

Dana-Farber Cancer Institute

A. Choudhury

18 views

CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Subgro…

Dana-Farber Cancer Institute

A. Choudhury

167 views

Challenging Genitourinary Tumors: What’s New in Prostate Cancer

Penn Medicine Abramson Cancer Center

V. Narayan

77 views

Stanford Medicine Historical Landscape of Testing: Blood-Based Diagn…

Stanford Medicine

J. Leppert

37 views

ASCO 2022 Updates on Molecular Based Imaging for Prostate Cancer: Re…

Nebraska Oncology Society

T. Hope

242 views

ASCO 2022 on the Latest Developments in mHSPC and mCRPC

ecancer

H. Payne, K. Chi, K. Miller, L. Krabbe

238 views

New Therapeutic Discoveries and Mechanisms for CRPC

Masonic Cancer Center, University of Minnesota

K. Kelly

92 views

Prostate Cancer Imaging Updates: What, Why, and When

Martin Allen-Auerbach

898 views

Cabazitaxel Activity in Men With mCRPC With & Without DNA Damage Rep…

Elena Castro

244 views

The Role of Biomarkers in mCRPC

Eleni Efstathiou

177 views

Finding the Optimal Sequence for mCRPC

Benjamin L. Maughan

349 views

Second Line Therapy Options in mCRPC

Karam Al-Issa

159 views

Patient Preference Between Cabazitaxel and Docetaxel for 1L Chemothe…

Giulia Baciarello

168 views